{"id":"W2564377031","doi":"10.1182/blood.v110.11.5178.5178","title":"Medical Costs of Adverse Events in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors: Canadian Perspective.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Nilotinib; Dasatinib; Medicine; Imatinib; Myeloid leukemia; Internal medicine; Adverse effect; Context (archaeology); Chronic myelogenous leukemia; Imatinib mesylate; Oncology; Leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001094659,0.000586022,0.0004855366,0.002703766,0.001369669,0.002169004,0.000683922,0.0009466309,0.007088853],"category_scores_gemma":[0.006370349,0.0002739245,0.001476694,0.00589953,0.0004330183,0.000750027,0.000692038,0.00185594,0.0003513242],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.05806631,"about_ca_system_score_gemma":0.06060015,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9583557,"about_ca_topic_score_gemma":0.9704731,"domain_scores_codex":[0.997835,0.000375823,0.0001712717,0.0001385467,0.001020455,0.0004588403],"domain_scores_gemma":[0.9938244,0.0003682928,0.001283321,0.00003529734,0.003107855,0.00138086],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001590712,0.0003204798,0.4498109,0.004781635,0.003330256,0.001477688,0.001291886,0.01422363,0.0007481819,0.03473751,0.2874648,0.2002223],"study_design_scores_gemma":[0.0003576014,0.0003783096,0.7666213,0.004548044,0.00187725,0.001426946,0.002637403,0.009326336,0.0002864701,0.003486011,0.2088219,0.0002324207],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.275243,0.2037844,0.001927935,0.2005908,0.001779636,0.0006032646,0.1452,0.0001000184,0.1707709],"genre_scores_gemma":[0.8827835,0.07937089,0.002087414,0.007701242,0.0007061115,0.0001318647,0.01973316,0.00003186162,0.007453839],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05806631,"threshold_uncertainty_score":0.4213026,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006123493295899442,"score_gpt":0.2386989307701567,"score_spread":0.2325754374742573,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}